Posted on Friday, October 1, 2004 - 07:00, By: ALSN Staff
Xaliproden fails in ALS, but hope remains
Posted on Friday, June 1, 2001 - 07:00, By: ALSN Staff
In a nine-month study of six people with ALS conducted at the Eleanor & Lou Gehrig MDA/ALS Center at Columbia-Presbyterian Medical Center in New York, investigators found that high-dose, orally administered coenzyme Q10 might be beneficial in preserving motor units in the disease. Because of...